Pathstone Family Office’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-164
Closed -$2K – 839
2019
Q1
$2K Hold
164
– – ﹤0.01% 794
2018
Q4
$2K Buy
+164
New +$2.42K ﹤0.01% 469
2018
Q2
– Sell
-500
Closed -$9K – 290
2018
Q1
$9K Buy
+500
New +$10.4K 0.01% 237
2017
Q4
– Sell
-500
Closed -$10K – 192
2017
Q3
$10K Hold
500
– – 0.01% 139
2017
Q2
$10K Hold
500
– – ﹤0.01% 316
2017
Q1
$12K Buy
+500
New +$13.5K 0.01% 272
2016
Q4
– Sell
-500
Closed -$11K – 177
2016
Q3
$11K Hold
500
– – 0.01% 123
2016
Q2
$11K Hold
500
– – 0.01% 133
2016
Q1
$9K Hold
500
– – 0.02% 121
2015
Q4
$8K Hold
500
– – 0.04% 60
2015
Q3
$7K Hold
500
– – 0.02% 111
2015
Q2
$9K Buy
+500
New +$10.4K 0.02% 95

Other funds holding PTEN

Pathstone Family Office's PTEN Position: Q2 2019 in Review

Pathstone Family Office sold out of Patterson-UTI (PTEN) in Q2 2019, closing a stake of 164 shares — an estimated $2K sold.

Pathstone Family Office first reported a position in PTEN in Q2 2015 and held it in 12 quarters. The position peaked at $12K in Q1 2017. 278 funds tracked by Wall St. Rank hold PTEN as of Q2 2019.

  • Pathstone Family Office reported no remaining Patterson-UTI position as of Q2 2019 after selling out during the quarter.
  • Pathstone Family Office sold 164 Patterson-UTI shares in Q2 2019, an estimated $2K.
  • Pathstone Family Office first reported a position in Patterson-UTI in Q2 2015 and held it in 12 quarters.
  • Pathstone Family Office's Patterson-UTI position peaked at $12K in Q1 2017.
  • 278 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2019.

Based on Pathstone Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.